Safety data Safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues. More information on AusVaxSafety active vaccine safety surveillance here. COVID-19 vaccines AusVaxSafety is conducting active surveillance of COVID-19 vaccine safety. Click here to access the latest data. Influenza vaccines AusVaxSafety is undertaking active surveillance of 2024 influenza vaccine safety. Click here to access the latest data. Mpox (monkeypox) vaccine AusVaxSafety is conducting active surveillance of mpox vaccine safety. Click here to access the latest data. National Immunisation Program schedule vaccines AusVaxSafety is undertaking active surveillance of NIP vaccine safety. Click here to access the latest data. Nirsevimab AusVaxSafety is undertaking enhanced surveillance of nirsevimab in Australia. Click here to access the latest data. RSV vaccines AusVaxSafety is undertaking enhanced surveillance of RSV vaccines in use in Australia. Click here to access the latest data. Shingrix® AusVaxSafety is undertaking enhanced surveillance of Shingrix® following addition to the NIP schedule. Safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine